Managing varicella zoster infection in pregnancy

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 4, 2007, Pages 290-296

  Gardella, Carolyn ^a   Brown, Zane A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247140255     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.4.290     Document Type: Article

References (27)

1. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits. JAMA 1991; 266:2724-2729.
2. US Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996; 45(RR-11):1-36.
3. US Centers for Disease Control and Prevention. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48(RR-6):1-5.
4. Varicella-zoster infection in pregnancy. N Engl J Med 1986; 315:1415-1417.
5. Harger JH, Ernest JM, Thurnau GR, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002; 185:422-427.
6. Smego RA Jr, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 1991; 78:1112-1116.
7. Pastuszak AL, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330:901-905.
8. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994, 343:1548-1551.
9. Brunell PA. Varicella in pregnancy, the fetus, and the newborn: problems in management. J Infect Dis 1992; 166(suppl 1):S42-S47.
10. Balducci J, Rodis JF, Rosengren S, Vintzileos AM, Spivey G, Vosseller C. Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol 1992, 79:5-6.
11. Meyers JD. Congenital varicella in term infants: risk reconsidered. J Infect Dis 1974; 129:215-217.
12. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 1989; 2:371-373.
13. Cox SM, Cunningham FG, Luby J. Management of varicella pneumonia complicating pregnancy. Am J Perinatol 1990; 7:300-301.
14. Mouly F, Mirlesse V, Meritet JF, et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997; 177:894-898.
15. Ferson MJ, Bell SM, Robertun PW. Determination and importance of varicella immune status of nursing staff in a children's hospital. J Hosp Infect 1990; 15:347-351.
16. Varicella vaccine - FAQs related to pregnancy. http:/www.cdc.gov/nip/ vaccine/varicella/faqs-clinic-vac-preg.htm. (Accessed January 31, 2007).
17. Brunell PA, Ross A, Miller LH, Kuo B. Prevention of varicella by zoster immune globulin. N Engl J Med 1969; 280:1191-1194.
18. Heuchan AM, Isaacs D. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases. Med J Aust 2001; 174:288-292.
19. US Centers for Disease Control and Prevention. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 2006; 55:209-210.
20. Asano Y, Yoshikawa T, Sugs S, et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993; 92:219-222.
21. Frenkel LM, Brown ZA, Bryson YJ, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991; 164:569-576.
22. Kimberlin DF, Weller S, Whitley RJ, et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998; 179:846-851.
23. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995; 28:281-290.
24. Stone KK, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 2004; 70:201-207.
25. Kimberlin D, Lin C-Y, Jacobs R, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223-229.
26. Sheffield JS, HJ, Lalbl V, Hotller LM, Sanchez P, Wendel GD. Valacyclovir suppression to prevent recurrent herpes at delivery: a randomized controlled trial [abstract]. Obstet Gynecol 2005; 104:5S.
27. Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infections: long-term safety and sustained efficacy after 20 years' experience with acyclovir. J Infect Dis 2002; 186(suppl 1):S40-S46.